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An “off the shelf” vascular allograft supports
angiogenic growth in three-dimensional tissue
engineering
Johann M. Zdolsek, MD,a Wayne A. Morrison, MB BS, MD,b,c Aaron M. Dingle, B Sc (Hons),b
Jason A. Palmer, B Sc (Hons),b Anthony J. Penington, MB BS,b,c and
Geraldine Margaret Mitchell, PhD,b,c Linköping, Sweden; and Melbourne, Australia
Objectives: Dense angiogenic sprouting occurs from arteriovenous loops (AVLs) incorporating autologous vein grafts
inserted into empty plastic chambers in vivo. The purpose of this study was to determine if angiogenesis from the AVL
was limited by substituting an “off the shelf” cold-stored allograft vein instead of an autologous vein.
Methods: Four Sprague Dawley rat groups (two AVL configurations two chamber types) were established for both 2-week
and 6-week harvest. Control AVLs were autologous femoral vein grafts harvested from the left femoral vein that were
surgically inserted between the cut femoral artery and vein on the right side. Experimental “allograft” AVLs were rat femoral
veins cold-stored (4°C, sterile) for 4 to 7 weeks and then microsurgically interposed between the right femoral artery and vein
of an unrelated rat. The two AVL types were inserted in one of two plastic chamber types – smooth or perforated. At harvest,
the AVL constructs were checked for patency, weighed, their volume determined, and histology undertaken. Morphometric
assessment of percent and absolute volume of major tissue components (including blood vessels) at 6 weeks was completed.
Results: There were no significant differences between autograft and allograft groups in construct weight, volume, or
morphology at 2 or 6 weeks. No statistical differences occurred in the percent or absolute vascular volume of AVLs
incorporating a cold-stored allograft vs autologous vein grafts at 6 weeks regardless of the chamber type. However, perforated
chambers caused significant increases in construct weight (P .015), volume (P .006), and percent and absolute connective
tissue volume at 6 weeks (P  .001) compared to smooth chamber constructs, regardless of the graft type.
Conclusion: Cold-stored small-caliber allografts interposed in AVLs do not inhibit microcirculatory development and can
be used in composite tissue engineering. (J Vasc Surg 2011;53:435-44.)
Clinical Relevance:The issue of providing a growing vascular network within three-dimensional tissue-engineered constructs
presents a major challenge to scientists and surgeons working in this field. Previously, many cell/scaffold constructs have been
implanted in vascular areas of the body and rely on neighboring capillaries at the implantation site to grow into the construct
and provide vascularization – this relatively slow process has been termed extrinsic vascularization. As an alternative, our group
has established an intrinsic vascularization model where larger three-dimensional constructs can be grown. A macrovascular
arteriovenous loop (AVL) is created by anastomosing a fresh autologous vein between the cut ends of the femoral artery and
vein. The AVL is placed in a plastic chamber and this construct spontaneously sprouts an extensive capillary network suitable
for the implantation of progenitor cells. Clinically, a more attractive option is to use an “off the shelf” synthetic or biologically
created vascular graft within the AVL. In this study, we have used cold-stored allograft veins as vascular grafts within the loop
and demonstrated that the angiogenic network generated is not significantly different to that formed when a fresh autograft
vein is anastomosed into the AVL. This result indicates that use of this vascular graft material will improve the options available
to vascular surgeons who may be involved in creating large tissue constructs. The use of this “off the shelf” biological graft will
shorten surgery times, operating costs, provide flexibility to the surgeon, and is a further significant advancement in composite
tissue engineering.
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tClinically useful bioengineered tissues require a vascu-
lar supply. To date, thin bioengineered tissues used clini-
cally (skin, cartilage) have only survived by diffusion of
oxygen and nutrients from the surrounding tissues.1,2
An alternate approach in three-dimensional tissue engi-
neering is to generate a vascular supply that grows with the
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doi:10.1016/j.jvs.2010.08.019esired tissue-specific progenitor cells to form an independent
ascularized mass of tissue,3 forming a primitive organ. To
chieve this, an AVL is surgically linked by a vein graft,4 and
prouts an extensive capillary network supporting implanted
ells.3
For clinical applicability, this should be an “off the
helf” product incorporating matrix, cells, and a vessel
edicle in a biodegradable chamber. This necessitates mi-
rovascular anastomosis of the pedicle to a “pre-prepared”
ascular graft, eliminating dissection of autologous vein
rafts, donor site scarring, and reducing operating times.
he challenge is to find a blood vessel substitute that
aintains angiogenic growth. The purpose of this study
as to explore the use of cold-stored allograft veins as “off
he shelf” vascular prostheses in the AVL chamber model.
Previous ultra-structural studies5,6 indicate no viableells in arteries and veins cold-stored for 4 weeks or longer.7
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February 2011436 Zdolsek et alThe collagen and elastin extra-cellular framework is main-
tained, including the internal elastic lamina.5,6 Fragments
of necrotic endothelial cells and smooth muscle cells are
seen within the extracellular framework. After reperfusion
(post-implantation) a few cells, fibroblasts and leucocytes,
migrate into the extracellular framework.7 Smooth muscle
cells do not repopulate the graft, and endothelial cells are
largely absent from the luminal surface.
Cold-stored allografts have been used without immu-
nosuppression5 achieving reasonable patency rates. As
cold-stored allografts partially repopulate with the recipi-
ent’s own cells,5 they may be an ideal “off the shelf”
biological vascular prosthesis that does not require immu-
nosuppression.5
This study investigates using cold-stored vein allografts
in AVLs in rat chambers and the ability of these constructs
to support microcirculatory growth, which was compared
to the same parameters of AVLs incorporating a standard
autologous vein at 2 and 6 weeks post-insertion.
In addition, we placed AVLs containing either autolo-
gous vein grafts or cold-stored allograft veins into one of
two types of plastic chambers, either a smooth closed
chamber, or chambers with multiple perforations. The
perforated chamber model8 has the advantage that extra
tissue growth can be achieved rapidly from ingrowths via
the chamber perforations, which contribute to three-di-
mensional construct size and vascularity.
MATERIALS AND METHODS
Animals. Fifty-one male Sprague Dawley rats weigh-
ing 350 to 550 grams were used in experiments approved
by St Vincent’s Hospital Animal Ethics Committee, Mel-
bourne, under the National Health and Medical Council of
Australia guidelines.
Vein graft harvest and allograft cold storage. With
the animal under general anesthesia, fresh vein autografts
(12-14 mm long) were obtained from the left femoral vein
of rats, flushed with sterile heparinized saline, and used
immediately in the same animal to create an AVL in the
right groin by anastomosing either end of the graft to the
divided proximal end of the right femoral artery and vein.
With the animal under general anesthesia, vein allo-
grafts (12-14 mm long) were obtained under sterile condi-
tions from the right and left femoral veins of donor male
rats before being euthanized. Allografts were flushed with
sterile heparinized saline solution before placement in
gauze moistened with sterile heparinized saline solution.
The allografts were kept at 4°C for 4 to 7 weeks.
Chambers. Dome-shaped polycarbonate chambers,
with and without perforations (perforation diameter 3 mm)
with an internal volume of 1.7 mL, were manufactured at
the Department of Chemical Engineering, University of
Melbourne. The perforated chambers had 7 perforations
on the chamber base and 13 perforations on the dome
shaped lid (Fig 1, a).
Experimental groups and operative procedure. The
animals were assigned to four different groups (N  11 or
12/group): Hroup 1: Autologous veins and unperforated (smooth)
chambers.
roup 2: Cold-stored vein allografts and smooth cham-
bers.
roup 3: Autologous veins and perforated chambers.
roup 4: Cold-stored vein allografts and perforated
chambers.
Within each group, animals were divided into sub-
roups that were euthanized at either 2 or 6 weeks.
Surgery to establish arteriovenous loops. The ani-
als were anesthetized with 75 mg/kg ketamine and 10
g/kg xylazine intraperitoneally. Through a groin inci-
ion, the right femoral artery and vein were dissected free of
onnective tissue, the saphenous and popliteal vessels were
ied distally, and the deep femoral vessels were coagulated.
he femoral vessels were divided distal to the branching of
he superficial inferior epigastric vessels and an AV shunt-
oop was created4 by interposing either the reversed autol-
gous or the reversed cold-stored allograft vein between
he proximal ends of the divided right femoral artery and
ein. The anastomoses were made end-to-end using a 10-0
onofilament suture. The AVLs were placed on a smooth
r perforated polycarbonate chamber base (Fig 1, b, and c).
he sectioned epigastric vessel branches were draped over
he edge of the chamber base, acting as anchor (tag) vessels,
hich were securely caught between the chamber base and
id when the lid was closed, thus reducing the chances of
VL movement within the chamber space. The lid in-
luded a window that did not compress the femoral vessels
s they entered the chamber. The closed chamber was
ositioned in the groin and secured by sutures to neighbor-
ng muscles.
Chamber harvest. Harvest of chambers was per-
ormed with the animal under general anesthesia at 2 or 6
eeks. Patency of the recipient artery and vein was evalu-
ted before removal of the chamber content and euthanasia
f the animals. The flow reflow patency test involved for-
eps clamping of the vessel, and clamping with additional
orceps immediately downstream to the first pair, and then
ulling the second forceps in a downstream direction so
hat a small section of the vessel was blood-free. While the
ownstream forceps were holding the vessel, the upstream
orceps were released; if the vessel was patent, the section of
he vessel between the forceps filled with blood.
Tissue processing and staining. The chamber con-
truct was weighed and its volume determined.9 The cham-
er tissue was cut serially into 1- to 2-mm thick vertical
ections and placed in 4% paraformaldehyde for fixation
vernight at 4°C. All tissue sections were processed and
mbedded in paraffin, cut into 5 m thick sections, and
outinely stained with hematoxylin and eosin, Masson’s
richrome (collagen), phosphotungstic acid-hematoxylin
PTAH; fibrin), or Giemsa (leukocyte identification).
Six-week specimens were lectin-labeled (biotinylated
riffonia simplicifolia lectin [Vector GSB1105 1:100; Vec-
or Laboratories, Burlingame, Calif]) followed by DAKO
RP-Streptavidin and DAB chromogen10 for endothelial
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Volume 53, Number 2 Zdolsek et al 437labeling and analyzed morphometrically. Tissues were pho-
tographed on a Zeiss Axioscope 2 microscope with an
Axiocam MRc5 camera using Axiovision 4.3 software
(Zeiss, Jena, Germany).
Morphometry. The percent volume of each tissue-
component in 6-week groups (lectin-labeled sections) was
determined on an Olympus BH-2 RFCA microscope using
stereological software (CAST 2, Olympus, Denmark) that
applied systematic random sampling to 5-micron thick paraf-
fin sections. The counter (author A.M.D.) was blinded to
section identity. Percent volume of various tissue compo-
nents11 was determined from a minimum of three complete
sections/construct. The software systematically, randomly
sampled 5% of the section and applied a 15-point grid to each
Fig 1. a, Tissue engineering chambers, volume 1.7 m
without perforations. b, Arteriovenous loops (AVLs) con
a perforated chamber base. c, AVL construct with co
unperforated chamber base. d, e, f, and g, Macroscopic
amount of vascularized (red) tissue and larger amount
(smooth chambers). In (e and g), note the well-vascula
growth from outside the chamber coming through the c
Weight, and (i), volume of constructs at harvest at 2 or 6
constructs significantly greater than smooth chamber
constructs significantly greater than smooth chamber cofield at20 magnification. The tissue components: AVL, new flood vessels, new connective tissue, fibrin, and miscellaneous
issue (hemorrhage and white blood cells) which lay beneath
ach point were recorded. The percent volume of individual
omponents was defined as the number of points counted for
hat component, divided by the total number of points
ounted per section multiplied by 100.
The absolute volume of tissue components was de-
ermined by multiplying the percent volume of individ-
al tissue components in each construct by the absolute
olume (mLs) of the whole construct (recorded at har-
est).11
Statistics. Statistical differences in weight and volume
ere determined using three-way analysis of variance
ANOVA; time point vs graft type vs chamber type; SPSS
ft: chamber with perforations, right: smooth chamber
t with autologous vein graft inserted (arrow) placed on
red vein-graft (arrow) inserted, sitting on a smooth
arance of constructs (arrows) at 6 weeks. Note smaller
rin (yellow material), not yet vascularized in (d and f)
tissue with knobs of new tissue originating from tissue
er perforations into the fibrin surrounding the AVL. h,
s (mean values SEM). *Weight of perforated chamber
tructs (P  .015). #Volume of perforated chamber
cts (P  .006).L. Le
struc
ld-sto
appe
of fib
rized
hamb
week
consor Windows version 15.0, Chicago, Ill).
h
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6 weeks were tested for statistical significance using two-
way ANOVA on the SPSS software.
RESULTS
Construct harvest. Fifty-one rats survived the anes-
Fig 2. Autologous vein graft constructs. a, Autologous
weeks. Note that new blood vessel/connective tissue (CT
Asterisk indicates hemorrhage into the fibrin. b, Autolog
has completely replaced the fibrin. c, The autograft vein w
occurred from the graft, and new blood vessels and CT su
AVL (A) in a perforated chamber at 2 weeks. Note t
perforations in the chamber. e, Autologous vein graft i
indicate the ‘knobs’ of tissue originating from chamber pe
intensely angiogenic tissue (note numerous lectin labeled
these new blood vessels). g, Autograft vein AVL construct i
ingrowths of vascularized tissue (VT) from outside the cham
this stage, the “knobs” of tissue are yet to unite with the vascu
h, Lectin labeled low power figure of an autograft vein AVL
tract of blood vessels (arrow) extending from the knob of tis
the AVL (A). i, The femoral vein portion of an occluded AV
the new microcirculatory bed into the femoral vein. a-e, g, a
f and h, Lectin labeling of 5m thick paraffin sections. Scal
200 m, scale bar in h 500 m.thesia, operative procedures, and the period until chamber iarvest. More complications occurred in the cold-stored
roup with one anesthetic death, four AVL dislocations,
nd two infections compared to two AVL dislocations in
he autologous vein group. These 9 animals were not
ncluded in the morphological evaluation.
The numbers of constructs examined morphologically
n arteriovenous loops (AVLs) in a smooth chamber at 2
th into the fibrin (F) from the AVL (A) is not complete.
ein in AVL (A) at 6 weeks. The vascularized CT growth
2 weeks, lined with endothelium (arrow). No branches
nd the autologous graft. d, Autologous vein graft in the
nobs” (arrows) of new tissue that originate from the
AVL (A) in a perforated chamber at 6 weeks. Arrows
tions. f, The autologous vein wall (asterisk) surrounded by
vessels outside the autograft vein, arrows indicate two of
rforated chamber at 2 weeks. Note that knob-like (arrows)
ia the perforations into fibrin (F) surrounding the AVL. At
d connective tissue growing around the AVL (not shown).
struct in a perforated chamber at 6 weeks demonstrating a
rmed via the perforation into the vascularized tissue around
monstrating dilated branches (arrow) bringing blood from
ematoxylin and eosin stained 5m thick paraffin sections.
in: a, b, d, e, and g, 1000 m. Scale bars in: c and fvein i
) grow
ous v
all at
rrou
he “k
n the
rfora
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n a pe
ber v
larize
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e barsn each group were:
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Volume 53, Number 2 Zdolsek et al 4392 weeks: autologous vein/smooth chamber: N  5, autol-
ogous vein/perforated chamber: N  6,
Cold-stored vein/smooth chamber: N  5, cold-stored
vein/perforated chamber: N  5,
6 weeks: autologous vein/smooth chamber: N  5, autol-
ogous vein/perforated chamber: N  5,
Cold-stored vein/smooth chamber: N  5, cold-stored
Fig 3. Cold-stored allograft vein constructs. a, Cold-sto
a smooth chamber at 2 weeks. The AVL (A) is surr
hemorrhage and fibrin still exist in the chamber (asterisk
smooth chamber at 6 weeks. The AVL is surrounded
disappeared. c, A cold-stored allograft vein wall at 2 we
lining (arrow) and is surrounded by fibrin (F). d, A cold-
AVL (A) is still largely surrounded by fibrin/hemorrhage
indicates “knob” of tissue entering construct via chamber
6 weeks in a perforated chamber. The amount of vascula
fibrin can be seen. Arrow indicates “knob” of tissue en
allograft vein in an AVL construct at 6 weeks. An endo
acellular (asterisk), and the graft is surrounded by new vas
at 6 weeks (asterisk) surrounded by numerous lectin-po
Lectin labeled allograft wall at 6 weeks at an anastomosis
and neointima formation (N). a, b, c, d, e, and f, Hema
h, Lectin labeled 5 m thick paraffin sections. Scale bars
and g, the scale bars  200 m, and in (h) the scale barvein/perforated chamber: N  6. iacroscopic evaluation
Patency. The recipient femoral artery and vein at the
hamber entrance were patent in all 42 constructs.
Construct weight and volume. Construct weight
nd volume (AVL plus new tissue, not including the cham-
er) were similar irrespective of the graft used (Fig 1, h and
llograft vein in arteriovenous loops (AVLs) construct in
ed by some vascularized connective tissue (CT), but
Cold-stored allograft vein in an AVL (A) construct in a
ascularized CT and the fibrin and hemorrhage have
is acellular (asterisk) and does not have an endothelial
d allograft vein at 2 weeks in a perforated chamber. The
isks) and new vascularized CT growth is minimal.Arrow
rations. e, A cold-stored allograft vein in an AVL (A) at
CT has greatly increased compared to 2 weeks and little
g construct via chamber perforations. f, A cold-stored
l lining is evident (arrow), the graft wall is still largely
ized CT. g, Lectin labeled cold-stored allograft vein wall
new capillaries (two capillaries indicated by arrows). h,
ating a lack of endothelial lining (lectin-negative, arrow)
in and eosin stained 5 m thick paraffin sections. g and
and e  1000 m, c and d, the scale bars  500 m, f
m.red a
ound
). b,
by v
eks, it
store
(aster
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terin
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toxyl
a, b,) at 2 and 6 weeks. However, weight (P  .015) and
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chambers was significantly larger than that of smooth
chambers regardless of the type of graft used or the time of
construct harvest. There were no interactions between
vessel type and chamber type.
Macroscopic appearance. At 2 weeks, a fibrin clot was
Fig 4. a-f, phosphotungstic acid-hematoxylin (PTAH
weeks. The arrows indicate peripheral fibrin. b, High pow
at 6 weeks, the peripheral fibrin (arrow) is reduced. d, Co
e, High power view of fibrin areas from (d). f, Cold-store
than at 2 weeks. g-h, Masson’s trichrome staining of con
(arrow) indicate new collagen around the arteriovenous
with a neointimal covering (arrow). The surrounding ne
tissue (blue areas). i, Cold stored vein allograft construct
the AVL (similar to g). j, High power view of the col
connective tissue including much collagen (blue areas). k
(bracket) at 2 weeks. Note cells in wall and endothelium (
Note a small accumulation of lymphocytes outside the ve
the graft wall (bracket) and the internal elastic lamina cov
Similar to l, but there are no lymphocytes in or near the
staining). Note the lack of cells in the graft wall and the
luminal surface - note there is no endothelium. Scale bars
bars  200 m. k, l, m, and n, scale bar  50 m.the dominant feature, and frequently a hemorrhagic bone occurred at the periphery. After 6 weeks, the fibrin
ad been largely replaced by vascularized connective
issue (Fig 1, d-g). In the smooth, unperforated cham-
ers, this process seemed to be slower (Fig 1, d and f)
han in the perforated chambers (Fig 1, e and g) and areas
f fibrin exudate persisted at 6 weeks in smooth cham-
ling of constructs. a, Autologous vein construct at 2
ew of fibrin areas from (a). c, Autologous vein construct
red vein construct at 2 weeks. The arrow indicates fibrin.
construct at 6 weeks, demonstrating less fibrin (arrow)
ts. g, Autologous vein construct at 2 weeks. Blue areas
(AVL). h, High power view of the autologous vein wall
ue includes many capillaries in a collagenous connective
weeks. Blue areas (arrow) indicate new collagen around
red vein wall (arrow) surrounded by new vascularized
iemsa staining of the graft wall. k, Autologous vein wall
) on luminal surface. l, Cold-stored vein wall at 2 weeks.
ll (arrow) - this was not common. There are few cells in
e luminal surface. m, Cold-stored vein wall at 2 weeks.
wall. n, High power view of graft wall (bracket; PTAH
en shreds of internal elastic lamina (arrow) on the graft
, d, f, g, and i, scale bar 2000 m. b, e, h, and j, scale) labe
er vi
ld-sto
d vein
struc
loop
w tiss
at 2
d sto
-m, G
arrow
in wa
ers th
graft
brok
: a, cers (Fig 1, f).
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Tissue growth related to graft type in smooth
chambers. At 2 weeks, highly vascularized tissue formed
in all specimens regardless of the graft type used (Figs 2, a;
and 3, a). Many new blood vessels sprouted from the
recipient femoral artery and vein, and extended as a ring of
angiogenic tissue spiraling around the AVL adventitial sur-
face, and also grew radially into the surrounding fibrin
matrix (Fig 4, a, b, d, and e). The graft segments acted as a
support for the new capillaries to advance into the core of
the chamber space. Hemorrhage from new capillaries was
evident at the boundary between new tissue and fibrin (Figs
2, a; and 3, a). At 2 weeks, the new angiogenic capillaries
(Fig 2, c) and arterioles in a collagenous connective tissue
(Fig 4, g-j), had only partially covered the autologous vein
graft or cold-stored allograft, which in some areas were still
surrounded by fibrin (Fig 3, c). There was no evidence of
capillary sprouting directly from either type of vein graft
(Figs 2, c; and 3, c).
After 6 weeks, hemorrhage was reduced (Figs 2, b; and
3, b) and was highly vascular (Figs 2, f; and 3, g). Connec-
tive tissue growth into the fibrin was complete in many
constructs, with new tissue reaching the outer edges of the
fibrin (Fig 4, c; and f). In some smooth chambers, some
fibrin persisted peripherally.
Tissue growth in perforated chambers. In perfo-
rated chambers, tissue growth from the AVL was identical
to that in smooth chambers. An obvious difference in
perforated chambers, regardless of graft type, was increased
construct size (compare Fig 1, d and e). Weight and volume
measurements confirmed this (Fig 1, h and i). This was the
result of perforated chambers including ‘knobs’ of vascu-
larized connective tissue in the outer regions of the fibrin
exudates (Figs 1, e and g; 2, d, e, g, and h; and 3, d and e)
which were derived from vascularized connective tissue that
had grown into the construct from outside the chamber via
the perforations. At 2 weeks, most “knobs” had not
reached the vascularized connective tissue around the AVL
(Fig 2, g). At 6 weeks, the two tissue sources were contin-
uous (Figs 2, e and h; and 3, e). Blood vessels penetrating
the chamber holes were recognized by their perpendicular
arrangement to the loop (Fig 2, h). Tissue growth was
complete in 6-week perforated chambers with little fibrin
persisting.
Morphology of the autograft and cold-stored allo-
graft veins. Autologous vein grafts were covered luminally
by endothelium (Fig 2, c and f). Limited neointima forma-
tion was confined to the anastomosis with the artery.
At 2 weeks, the cold-stored allograft vein wall was
largely acellular (Fig 3, c) with connective tissue cells evi-
dent in the outer regions of the wall. Occasional fibroblasts
within the wall were evident (Fig 4, l and m); the internal
elastic lamina was often seen intact or segmented at the
luminal surface, with no cellular covering (Fig 4, n). Endo-
thelium was occasionally observed lining the internal sur-
face in 6-week cold-stored allografts (Fig 3, f), but gener-
ally there was no luminal covering. Neointima formation gccurred at the anastomoses (Fig 3, h), and in some
-week allografts it extended further, although complete
uminal coverage was never achieved. Giemsa staining
id not indicate any infiltration of the cold-stored allo-
raft wall by a leukocyte invasion, and only rarely were
mall groupings of lymphocytes seen outside the cold-
tored allograft wall (Fig 4, l).
Histological assessment of arteriovenous loop pa-
ency. At 2 weeks, patency of autologous veins was 60% in
mooth chambers, and 67% in perforated chambers, while
old-stored allografts had 80% patency regardless of the
hamber type. At 6 weeks, autologous veins in smooth
hambers had 20% patency, and in perforated chambers,
0% were patent. Cold-stored allograft veins at 6 weeks had
5% patency in smooth chambers and 67% patency in
erforated chambers (Table).
Some constructs with occluded AVLs (both graft types)
emonstrated prominent, wide vascular channels (Fig 2, i)
hich seemed to drain into the femoral vein. There was no
vidence of tissue necrosis in any construct.
Morphometry. The percent and absolute vascular
olume generated by constructs containing autologous
eins or cold-stored allografts were not significantly differ-
nt (Fig 5, b and d), nor were these parameters different in
mooth and perforated chambers. However, the absolute
ascular volume was considerably higher in perforated
hambers, although not significantly (Fig 5, d), due to
ariance within the raw data.
The AVL, fibrin, and miscellaneous components dem-
nstrated no difference in percent or absolute volume
enerated with either graft type, or in smooth or perforated
hambers (Fig 5, a and c).
However, a significant increase occurred in percent and
bsolute connective tissue volume in perforated compared
o smooth chambers (P  .001, for both measurements,
igs 5, a and c).
Examination of new tissue generated in relation to
atency of the arteriovenous loop. When the percent
ascular volume was related to graft type and occlusion vs
atency (two-way ANOVA), there was no significant dif-
erence between any groups (Fig 6, a). In addition, there
as no difference in the percent fibrin volume, or new
onnective tissue volume in constructs with occluded AVLs
ompared to patent AVLs when examined in relation to
able. Histologically assessed patency
xperimental group
2-week
harvest
patency
6-week harvest
patency
utologous vein/smooth chamber 60% 20%
utologous vein/perforated chamber 67% 60%
old-stored vein/smooth chamber 80% 75% (1 excl.a)
old-stored vein/perforated
chamber
80% 67%
Specimen somewhat broken up – difficult to evaluate patency.raft type (Fig 6, b and c).
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Creation of arteriovenous loop microcirculatory
networks using cold-stored allograft veins compared to
autologous veins. The incorporation of a cold-stored al-
lograft vein into an AVL does not inhibit angiogenic
growth, as measured by the percent and absolute vascular
volume of constructs at 6 weeks, compared to AVLs incor-
porating a standard autologous vein.
The new vascular network forms in the AVL construct by
sprouting from the recipient artery and vein within the cham-
ber,10 but not from either graft type. Earlier studies12 estab-
lished that the AVL produces more vascularized tissue than a
Fig 5. a, The percent volume of arteriovenous loop (AV
tissue, and blood in four groups at 6 weeks: A, autograft
S, smooth chambers. There was no difference in the tissue
allograft veins. However, in relation to chamber type,
perforated chambers (regardless of graft type) compared
volume of new blood vessels in four groups at 6 weeks. T
graft or chamber type. c, The absolute vascular volume o
only significant difference was a significant increase in ne
(#) regardless of whether autograft or cold-stored allograf
of all four groups at 6 weeks. Although it seems that vascu
significant. There was no difference in vascular volume gligated femoral pedicle in the chamber. Maintenance of AVL olood flow and, therefore, shear stress stimulates angiogene-
is,13 and may increase angiogenesis in this model. In addi-
ion, it was noted that the entire AVL loop seems to act as a
caffold for penetration of vascularized connective tissue into
he deeper regions of the chamber.
The autologous vein graft does not produce vascular
prouts in the first 2 weeks, the pivotal period for sprout-
ng.10 Occasional connections between the graft and the
urrounding capillary network occur later.10,14 As forma-
ion of the AVL microcirculatory network is not dependant
n sprouts from the graft, the insertion of a cold-stored
llograft vein could not negatively influence the generation
nstruct tissue components AVL, fibrin, new connective
; CS, cold-stored allograft vein; P, perforated chambers;
osition in constructs with autograft veins or cold-stored
was a significant increase in new connective tissue in
mooth chambers (*P  .001). b, The percent vascular
was no difference in percent vascular volume related to
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assessment of the femoral artery and vein patency indicated
100% patency. Histological assessment indicated that AVLs
had a lower patency than that suggested by surgical assess-
ment, although the study determined that patency of the
AVL did not influence the amount of vascularized tissue
produced.
The cause of occlusions was not obvious. Some neoin-
tima formation was seen in both graft types, but did not
seem to be associated with thrombus formation. There was
no evidence of an immune cellular rejection response to the
Fig 6. a, Comparison of the new percent vascular v
constructs and cold-stored vein constructs. There was no
based on patency status. b, Comparison of the percent
autologous vein constructs and cold-stored vein cons
connective tissue generated based on patency status. c, C
and occluded autologous vein constructs and cold-store
percent fibrin volume based on patency status. AVLs, Arcold-stored allografts. bThe discrepancy between macroscopic and histological
atency seems related to where patency was assessed. Mac-
oscopic patency was assessed outside the construct, while
istological patency assessed the entire AVL. Occlusion was
bserved within the loop in both graft types. The presence
f wide vascular channels connecting to the recipient fem-
ral vein in some occluded AVLs suggests that new vascular
hannels are developed to overcome occlusion, and indi-
ates that the AVL vascular network has considerable
uilt-in plasticity.13
Smooth vs perforated chambers. Perforated cham-
e generated in patent and occluded autologous vein
cant difference in the percent vascular volume generated
ective tissue volume generated in patent and occluded
. There was no significant difference in the percent
arison of the percent fibrin volume generated in patent
n constructs. There was no significant difference in the
enous loops.olum
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tissue “knobs” growing into the chamber via perforations.
The perforated chamber has the advantage that extra tissue
growth can be achieved quickly, enabling rapid three-
dimensional soft tissue construction. However, because the
additional tissue “tethers” the construct, perforated con-
structs are less suitable than smooth chamber constructs for
transplantation based on the vascular pedicle.
Future directions. As the AVL model is not depen-
dant on capillary growth from the vascular graft, an attrac-
tive clinical option would be to use either synthetic or
allogenic vessels, instead of autologous veins, thus reducing
donor site morbidity and operating times. Potential sources
of human allograft veins for cold storage are the umbilical
cord blood vessels or cadaver sources.
Cold-stored venous allografts can be used as a vascular
prosthesis to effectively generate an extensive capillary net-
work within the AVL chamber model. Future endeavors
could use this graft model with the plastic chamber pre-
packaged as an “off the shelf” kit to initiate the growth of a
vascularized three-dimensional tissue, and seeded with
stem/progenitor cells, growth, and differentiation factors
to produce a specific organ/tissue. The chamber will be
created from a biodegradable polymer, which is currently
being trialed in rats and pigs.
CONCLUSION
This study demonstrates that hypoimmunogenic cold-
stored vein allografts support the growth of highly vascu-
larized connective tissue in the rat AVL model to the same
degree as autologous vein grafts. This opens the way for
“off-the-shelf” devices that eliminate the need for autolo-
gous veins in our tissue-engineering model.
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